Necroptosis Antibody Sampler Kit - #KF2032
产品描述
货号:
KF2032
产品:
Necroptosis Antibody Sampler Kit
应用:
WB, IHC, IF/ICC, ELISA
反应:
Hm, Ms, Rt, Pg, Bv, Gt, Mk, Ck, Rb
产品包含:
货号 | 产品 | 规格 | 来源 | 应用 | 反应 | 文献引用 |
---|---|---|---|---|---|---|
AF7877 | RIPK1 Ab | 20ul | Rabbit | WB | Hm,Ms,Rt | 8 |
AF2398 | P-RIPK1 (Ser166) Ab | 20ul | Rabbit | WB,IHC,IF/ICC | Hm,Ms | 4 |
DF7412 | MLKL Ab | 20ul | Rabbit | WB,IHC,IF/ICC | Hm,Ms,Rt | 22 |
AF7420 | P-MLKL (Ser358) Ab | 20ul | Rabbit | WB,IHC | Hm,Ms,Rt | 34 |
AF7942 | RIP3 Ab | 20ul | Rabbit | WB,IHC | Hm,Ms,Rt | 11 |
AF3893 | P-RIPK3 (Ser227) Ab | 20ul | Rabbit | IHC | Hm,Rt | 0 |
AF7021 | GAPDH Ab | 20ul | Rabbit | WB,IHC,IF/ICC | Hm,Ms,Rt,Pg,Bv,Gt,Mk,Ck | 760 |
S0001 | Goat Anti-Rabbit IgG HRP | 100ul | Goat | WB,IHC,ELISA | Rb | 579 |
简介:
Necroptosis is a form of programmed cell death that shares features with both apoptosis and necrosis. It is initiated by a specific signaling cascade and is characterized by cellular swelling, plasma membrane rupture, and the release of intracellular contents, leading to inflammation and immune responses.
储存条件:
Store at -20 °C. Stable for 12 months from date of receipt.
Necroptosis is a form of programmed cell death that shares features with both apoptosis and necrosis. It is initiated by a specific signaling cascade and is characterized by cellular swelling, plasma membrane rupture, and the release of intracellular contents, leading to inflammation and immune responses.
The necroptosis pathway is primarily mediated by the receptor-interacting protein kinase 1 (RIPK1) and receptor-interacting protein kinase 3 (RIPK3), as well as by mixed lineage kinase domain-like protein (MLKL).
1. **Initiation:** Necroptosis can be triggered by various extracellular signals, including activation of death receptors (e.g., TNF receptor 1), Toll-like receptors, or pattern recognition receptors. Under certain conditions, when caspase-8 activity is inhibited or deficient, RIPK1 forms a complex with RIPK3 via their RIP homotypic interaction motif (RHIM) domains, leading to the activation of RIPK3.
2. **Activation of RIPK3:** Activated RIPK3 phosphorylates MLKL, leading to its oligomerization and translocation to the plasma membrane.
3. **Plasma membrane disruption:** Oligomerized and phosphorylated MLKL disrupts the integrity of the plasma membrane, leading to cellular swelling and plasma membrane rupture, ultimately resulting in necroptotic cell death.
Key proteins involved in the necroptosis pathway include:
1. **Receptor-interacting protein kinase 1 (RIPK1):** RIPK1 is a serine/threonine kinase that plays a central role in regulating cell death and inflammation. It is recruited to death receptors and mediates signaling pathways that lead to apoptosis, necroptosis, or survival, depending on the cellular context.
2. **Receptor-interacting protein kinase 3 (RIPK3):** RIPK3 is a closely related kinase to RIPK1 and forms a complex with RIPK1 under conditions of caspase-8 inhibition or deficiency. Activated RIPK3 phosphorylates MLKL, leading to necroptotic cell death.
3. **Mixed lineage kinase domain-like protein (MLKL):** MLKL is the effector protein of necroptosis. Phosphorylated MLKL undergoes conformational changes and translocates to the plasma membrane, where it disrupts membrane integrity and induces necroptotic cell death.
Necroptosis plays a critical role in various physiological and pathological processes, including development, immune responses, and tissue injury. Dysregulation of necroptosis has been implicated in various diseases, including inflammatory disorders, neurodegenerative diseases, ischemia-reperfusion injury, and infectious diseases. Therefore, understanding the molecular mechanisms underlying necroptosis and the roles of key proteins involved in this process is essential for elucidating the pathogenesis of these diseases and for developing therapeutic strategies to target necroptosis for the treatment of these disorders.
The necroptosis pathway is primarily mediated by the receptor-interacting protein kinase 1 (RIPK1) and receptor-interacting protein kinase 3 (RIPK3), as well as by mixed lineage kinase domain-like protein (MLKL).
1. **Initiation:** Necroptosis can be triggered by various extracellular signals, including activation of death receptors (e.g., TNF receptor 1), Toll-like receptors, or pattern recognition receptors. Under certain conditions, when caspase-8 activity is inhibited or deficient, RIPK1 forms a complex with RIPK3 via their RIP homotypic interaction motif (RHIM) domains, leading to the activation of RIPK3.
2. **Activation of RIPK3:** Activated RIPK3 phosphorylates MLKL, leading to its oligomerization and translocation to the plasma membrane.
3. **Plasma membrane disruption:** Oligomerized and phosphorylated MLKL disrupts the integrity of the plasma membrane, leading to cellular swelling and plasma membrane rupture, ultimately resulting in necroptotic cell death.
Key proteins involved in the necroptosis pathway include:
1. **Receptor-interacting protein kinase 1 (RIPK1):** RIPK1 is a serine/threonine kinase that plays a central role in regulating cell death and inflammation. It is recruited to death receptors and mediates signaling pathways that lead to apoptosis, necroptosis, or survival, depending on the cellular context.
2. **Receptor-interacting protein kinase 3 (RIPK3):** RIPK3 is a closely related kinase to RIPK1 and forms a complex with RIPK1 under conditions of caspase-8 inhibition or deficiency. Activated RIPK3 phosphorylates MLKL, leading to necroptotic cell death.
3. **Mixed lineage kinase domain-like protein (MLKL):** MLKL is the effector protein of necroptosis. Phosphorylated MLKL undergoes conformational changes and translocates to the plasma membrane, where it disrupts membrane integrity and induces necroptotic cell death.
Necroptosis plays a critical role in various physiological and pathological processes, including development, immune responses, and tissue injury. Dysregulation of necroptosis has been implicated in various diseases, including inflammatory disorders, neurodegenerative diseases, ischemia-reperfusion injury, and infectious diseases. Therefore, understanding the molecular mechanisms underlying necroptosis and the roles of key proteins involved in this process is essential for elucidating the pathogenesis of these diseases and for developing therapeutic strategies to target necroptosis for the treatment of these disorders.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.